Differences in mechanisms of action between paclitaxel, doxorubicin and cisplatin in breast cancer may be accompanied by a corresponding diversity in gene expression patterns. We analyzed gene ...

In a cohort of 62 patients with HCC there were 141 sessions of TACE with DEB loaded with doxorubicin. [56] At 9 months of follow-up, the sustained objective response (European Association for the ...

The drug is associated with abnormal lipid levels in blood plasma, but the molecular mechanisms responsible ... capabilities for treating hepatocellular carcinoma (HCC), a deadly form of liver ...